cabometyx
ipsen pharma - cabozantinib (s)-malate - carcinoma, renal cell; carcinomas, hepatocellular - antineoplastiset aineet - renal cell carcinoma (rcc)cabometyx is indicated as monotherapy for the treatment of advanced renal cell carcinoma (rcc):in treatment-naïve adults with intermediate or poor risk,in adults following prior vascular endothelial growth factor (vegf)-targeted therapy. cabometyx, in combination with nivolumab, is indicated for the first-line treatment of advanced renal cell carcinoma in adults. hepatocellular carcinoma (hcc)cabometyx is indicated as monotherapy for the treatment of hepatocellular carcinoma (hcc) in adults who have previously been treated with sorafenib.
mirvaso
galderma international - brimonidiinitartraatti - ihosairaudet - muut dermatologiset valmisteet - mirvaso on tarkoitettu rosacean kasvojen erythema-oireen hoitoon aikuispotilailla.
noropraz 18.7 mg/g + 140.3 mg/g oraalipasta
norbrook laboratories (ireland) limited - ivermectin, praziquantel - oraalipasta - 18.7 mg/g + 140.3 mg/g - ivermektiini
terbinafin galderma 250 mg tabletti
galderma nordic ab - terbinafini hydrochloridum - tabletti - 250 mg - terbinafiini
loceryl 5 % lääkekynsilakka
galderma nordic ab - amorolfine hydrochloride - lääkekynsilakka - 5 % - amorolfiini
basiron ac 5 % geeli
galderma nordic ab - benzoyl peroxide - geeli - 5 % - bentsoyyliperoksidi
basiron ac 10 % geeli
galderma nordic ab - benzoyl peroxide - geeli - 10 % - bentsoyyliperoksidi
basiron ac wash 5 % geeli
galderma nordic ab - benzoyl peroxide - geeli - 5 % - bentsoyyliperoksidi
differin 1 mg/g geeli
galderma nordic ab - adapalene - geeli - 1 mg/g - adapaleeni
rozex 0.75 % emulsiovoide
galderma nordic ab - metronidazole - emulsiovoide - 0.75 % - metronidatsoli